Edward Stelmakh

OPRX

Edward Stelmakh serves as Chief Finance & Strat Officer at OptimizeRx Corporation (OPRX). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.

Total Buys

1 trades

$46.3K

Total Sells

3 trades

$148.0K

Net Position

Net Seller

$101.7K

Companies Traded

OPRX

Active Period

Aug 2022 – Dec 2025

4 total trades

Most Recent

Sell OPRX

Dec 23, 2025 · $46.6K

Edward Stelmakh's Insider Trading at OptimizeRx Corporation (OPRX)

Buys

1 · $46.3K

Sells

3 · $148.0K

Total Shares Bought

3,000

Total Shares Sold

9,452

OPRX Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value	Shares After
Dec 23, 2025	Sell	3,658	$12.74	$46.6K	0
Dec 19, 2025	Sell	1,388	$13.51	$18.8K	0
Oct 3, 2025	Sell	4,406	$18.75	$82.6K	0
Aug 17, 2022	Buy	3,000	$15.43	$46.3K	3,000

Related Insiders

Marion Odence-Ford

Chief Legal & Admin Officer

OPRXSell · Feb 11, 2026

Stephen L Silvestro

Chief Executive Officer

OPRXSell · Dec 23, 2025

Theresa Greco

Chief Commercial Officer

OPRXSell · Dec 23, 2025

Doug Besch

Chief Product & Tech Officer

OPRXSell · Dec 23, 2025

Brendan W. Merrell

CHIEF OPERATING OFFICER

OPRXSell · Dec 19, 2025

Andrew J. D'Silva

Chief Business Officer

OPRXSell · Dec 19, 2025

Patrick D Spangler

Director

OPRXSell · Aug 28, 2025

Explore More Insider Trading Data

OPRX Insider Trading Activity

View all insider trades at OptimizeRx Corporation

Healthcare Sector Insider Trades

See insider activity across healthcare stocks

Latest Insider Buys

Most recent insider purchases across all stocks

CEO Stock Purchases

Track CEO buying activity